Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
75 participants
INTERVENTIONAL
2018-05-26
2018-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Tooth sensitivity will be assessed before, during and 24 hours after the procedure using analog visual and verbal scales. Color alteration will be assessed by a Vita Guide scale at the end of the last session. Relative risk to sensitivity will be calculated and adjusted by session; while comparison of overall risk will performed by McNemar's test. Data on the sensitivity level and color shade will be subjected to the Friedman, Wilcoxon (α = 0.05). If necessary, multiple comparation will be done using Tukey's test.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Potassium Oxalate and Potassium Nitrate and Post-bleaching Sensitivity
NCT02941653
Different Concentrations of Potassium Nitrate in In-office Tooth Bleaching Sensitivity
NCT03323372
Potassium Oxalate and Placebo and Post-bleaching Sensitivity
NCT03065673
Effect of Laser and Potassium Nitrate Application on the Sensitivity Control in Bleached Teeth
NCT03434782
Effect of 1.5% Potassium Oxalate on the Control of Tooth Sensitivity and Color Change After Home Bleaching
NCT05028335
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The patients included will be submitted to two in-office bleaching sessions receiving the potassium nitrate 5% or placebo gel (prior the bleaching session, for 10 minutes), associated to normal toothpaste or potassium nitrate containing toothpaste (15 days prior and during the bleaching procedure).
A delay of 1 week between the sessions will be established.
Participants:
Patients included in this clinical trial will be between 18 and 29 years old with good oral health, all anterior tooth healthy and to agree with TCLE (Term of Free and Informed Consent). Only patients presenting all six upper anterior teeth with shade mismatching with 2.5 M2 (VitaClassicalscale, Vita-Zahnfabrik, Bad Sackingen, Germany).
Patients with any of the six upper anterior teeth with caries, restoration, severe discoloration (e.g., stains caused by tetracycline), enamel hypoplasia, gingival recession, dentin exposure, pulpitis, or endodontics will be excluded. Participants submitted to previous bleaching procedures, presenting prior tooth sensitivity, known allergy to any component of medication used in the study, pregnant or breastfeeding, lack the tretament will be also excluded.
Sample Size Calculation:
The sample calculation will be based on the primary binary outcome (sensitivity risk 24 hours after the procedure) for superiority trial. Power of the test will be set at 80%, considering a type I error of 0.05; risk to tooth sensitivity for control and experimental group of 25,2% with reduction of 60%. The calculation resulted in 75 patients.
Randomization:
A randomized list will be computer-generated by a person not involved in intervention or evaluation. The participants were defined as blocks in the randomization process, where the sequence of treatment (placebo or etodolac) will be randomly set for each block by using computer-generated tables (www.sealedenvelope.com). The sequence will be inserted into sealed envelopes numbered from 1 to 75 that were opened by the operator only at the moment of the intervention. The patients were numbered according to the sequence of enrollment. Neither the participant nor the operator will know the group allocation determining blinding to the protocol.
Baseline evaluation:
Prior to bleaching procedure, the teeth will be cleaned using rubber cups associated to pumice and water. The shades of six upper anterior teeth will be assessed on a baseline using the Vita classical guide scale.
Intervention:
Prior to each bleaching session, the patients will receive the potassium nitrate 2% or placebo Gel for 10 minutes. Also, Normal and potassium nitrate toothpaste will be used before and during the bleaching tretament, as follows: group 1: placebo gel + Colgate toothpaste; Group 2: Placebo gel + Nitrate toothpaste Sensodyne and Group 3: Potassium Nitrate + Colgate toothpaste.
Neither the operators responsible for intervention and evaluation nor the patients knew the content which treatment will be done.
A light-cured resin dam will be applied on the gingival tissue corresponding to the teeth to be bleached.
A 35% hydrogen peroxide based bleaching agent (DFL) will be mixed and applied on the vestibular surface of teeth, remaining for 40 minutes. After this time, the bleaching agent will be removed. A second session will be carried out after 1 week following the same procedures.
Evaluations:
The tooth sensitivity reported by patients will be assessed using a visual analog scale (VAS) and verbal rating scale (VRS). The VAS consisted of a scale 10 cm in length ranging from green (absence of pain) to red (unsupportable pain). The patient set his or her level of sensitivity by pointing to the color corresponding to this level, while the distance from this point to the green border will be recorded. For VRS, the patient reported his or her level of sensitivity based on scores: 0 = none, 1 = light, 2 = moderate, 3 = considerable and 4 = severe. The tooth sensitivity will be assessed during the bleaching, immediately after bleaching agent removal and after 24 hours. For this last assessment, only the VRS will be used. Tooth sensitivity will be measure: baseline, at 40 minutes during the bleaching procedure, after the bleaching procedure and 24 hours after. One week after each session the tooth color will be evaluated again using the same procedure described previously.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo gel + Normal Toothpaste
The patient will receive the application of placebo gel on vestibular surface teeth, for 10 minutes and will use the normal toothpaste (Colgate).
Placebo gel + Normal Toothpaste
* 15 days before and during the period of bleaching sessions: Tooth paste used will be normal (Colgate).
* Teeth will be cleaned using rubber cups associated to pumice and water;
* Relative isolation with roller cotton will be done;
* Prior to each bleaching session, the patients will receive the placebo gel application on vestibular surface, for 10 minutes.
* Gingival dam will be performed using a fluid resin.
* A 35% hydrogen peroxide based bleaching agent will applied on the vestibular surface of teeth, remaining for 40 minutes.
Placebo Gel + Potassium Nitrate Toothpaste
The patient will receive the application of placebo gel on vestibular surface teeth, for 10 minutes and will use the Potassium nitrate toothpaste (Sensodyne).
Placebo Gel + Potassium Nitrate Toothpaste
* 15 days before and during the period of bleaching sessions: Tooth paste used will be normal tooth paste (Colgate).
* Teeth will be cleaned using rubber cups associated to pumice and water;
* Relative isolation with roller cotton will be done;
* Prior to each bleaching session, the patients will receive the 5% Potassium Nitrate gel application on vestibular surface, for 10 minutes.
* Gingival dam will be performed using a fluid resin.
* A 35% hydrogen peroxide based bleaching agent will applied on the vestibular surface of teeth, remaining for 40 minutes.
Potassium Nitrate Gel + Normal Toothpaste
The patient will receive the application of 5% Potassium nitrategel on vestibular surface teeth, for 10 minutes and will use the normal toothpaste (Colgate).
Potassium Nitrate Gel + Normal Toothpaste
* 15 days before and during the period of bleaching sessions: Tooth paste used will be Potassium Nitrate containing (Sensodyne).
* Teeth will be cleaned using rubber cups associated to pumice and water;
* Relative isolation with roller cotton will be done;
* Prior to each bleaching session, the patients will receive the placebo gel application on vestibular surface, for 10 minutes.
* Gingival dam will be performed using a fluid resin.
* A 35% hydrogen peroxide based bleaching agent will applied on the vestibular surface of teeth, remaining for 40 minutes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo gel + Normal Toothpaste
* 15 days before and during the period of bleaching sessions: Tooth paste used will be normal (Colgate).
* Teeth will be cleaned using rubber cups associated to pumice and water;
* Relative isolation with roller cotton will be done;
* Prior to each bleaching session, the patients will receive the placebo gel application on vestibular surface, for 10 minutes.
* Gingival dam will be performed using a fluid resin.
* A 35% hydrogen peroxide based bleaching agent will applied on the vestibular surface of teeth, remaining for 40 minutes.
Placebo Gel + Potassium Nitrate Toothpaste
* 15 days before and during the period of bleaching sessions: Tooth paste used will be normal tooth paste (Colgate).
* Teeth will be cleaned using rubber cups associated to pumice and water;
* Relative isolation with roller cotton will be done;
* Prior to each bleaching session, the patients will receive the 5% Potassium Nitrate gel application on vestibular surface, for 10 minutes.
* Gingival dam will be performed using a fluid resin.
* A 35% hydrogen peroxide based bleaching agent will applied on the vestibular surface of teeth, remaining for 40 minutes.
Potassium Nitrate Gel + Normal Toothpaste
* 15 days before and during the period of bleaching sessions: Tooth paste used will be Potassium Nitrate containing (Sensodyne).
* Teeth will be cleaned using rubber cups associated to pumice and water;
* Relative isolation with roller cotton will be done;
* Prior to each bleaching session, the patients will receive the placebo gel application on vestibular surface, for 10 minutes.
* Gingival dam will be performed using a fluid resin.
* A 35% hydrogen peroxide based bleaching agent will applied on the vestibular surface of teeth, remaining for 40 minutes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All anterior tooth healthy
* To agree with TCLE (Term of Free and Informed Consent).
* Only patients presenting all six upper anterior teeth with shade mismatching with 2.5 M2 (VitaClassicalscale, Vita-Zahnfabrik, Bad Sackingen, Germany).
Exclusion Criteria
* Restoration in anterior tooth, severe discoloration (e.g., stains caused by tetracycline), enamel hypoplasia, gingival recession, dentin exposure, pulpitis, or endodontics will be excluded.
* Participants submitted to previous bleaching procedures
* Presenting prior tooth sensitivity
* known allergy to any component of medication used in the study
* being pregnant or breastfeeding.
18 Years
29 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johnny Alexandre Oliveira Tavares
UNKNOWN
Universidade Federal de Sergipe
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Flavia Pardo Salata Nahsan
Clinical Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Federal University of Sergipe
Aracaju, Sergipe, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UFSergipe.
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.